CREB-IN-1 TFA
CREB-IN-1 TFA is a potent, orally active CREB inhibitor (IC50=0.18 µM). CREB-IN-1 TFA inhibits breast cancer cell growth.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 2912285-84-6
- Formel: C35H32ClF3N3O10P
- Molecular Weight:778.06
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Biologische Aktivität
Beschreibung
IC50 & Target
IC50: 0.18 µM (CREB)[1]
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| MDA-MB-231 | GI50 |
0.38 μM
Compound: 3
|
Growth inhibition of human MDA-MB-231 cells incubated for 72 hrs by MTT assay
Growth inhibition of human MDA-MB-231 cells incubated for 72 hrs by MTT assay
|
[PMID: 35300089] |
| MDA-MB-468 | GI50 |
0.021 μM
Compound: 3
|
Growth inhibition of human MDA-MB-468 cells incubated for 72 hrs by MTT assay
Growth inhibition of human MDA-MB-468 cells incubated for 72 hrs by MTT assay
|
[PMID: 35300089] |
In Vitro
CREB-IN-1 TFA (compound 3) (HEK 293T cells; 100 µM; 24 hours) inhibits CREB-mediated gene transcription with an IC50 of 0.18 µM[1].
CREB-IN-1 TFA (100 µM; 3 days) shows potent activities in MDA-MB-231 (GI50=0.38 µM) and MDA-MB-468 (GI50=0.021 µM) cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HEK 293T cells
-
Concentration:100 µM
-
Incubation Time:24 hours
-
Result:Inhibited CREB-mediated gene transcription with an IC50 of 0.18 µM.
-
Cell Line:MDA-MB-231, MDA-MB-468 cells
-
Concentration:100 µM
-
Incubation Time:3 days
-
Result:Showed potent activities in MDA-MB-231 (GI50 =0.38 µM) and MDA-MB-468 (GI50 =0.021 µM) cells.
In Vivo
Pharmacokinetic Parameters of CXCR4 antagonist 4 in mice [1].
| route | dose(mg/kg) | t1/2(h) | Tmax(h) | Cmax(ng/mL) | AUC0-t(ng·hr/mL) | AUC0-∞((ng·hr/mL) | bioavailability (F%) |
| IP | 10 | 4.2 | 1.0 | 156 | 892 | 910 | 144 |
| PO | 20 | 5.5 | 2.00 | 73 | 468 | 479 | 38 |
Mice, 5 mg/kg IV; 10 mg/kg IP; 20 mg/kg PO[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Female C57BL/6 mice[1]
-
Dosage:5, 10, 20 mg/kg (dissolved in 0.1 N NaOH in ddI H2O at 40 mg/mL and further dilutions were made using ddI H2O)
-
Administration:Showed much improve oral bioavailability at 38%.
-
Result:Showed much improve oral bioavailability at 38%.
Chemical Information
-
CAS. Nr. 2912285-84-6
-
Molecular Weight 778.06
-
Formel C35H32ClF3N3O10P
-
SMILES
NCCCOC1=C(C=C2C=CC=CC2=C1)C(NCCOC3=CC4=CC=CC=C4C=C3C(NC5=CC=C(C=C5OP(O)(O)=O)Cl)=O)=O.OC(C(F)(F)F)=O
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
CREB-IN-1 TFA Related Classifications
HY-144318 Related Classifications
Powered by Bioz